NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 264 filers reported holding NEKTAR THERAPEUTICS in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | -99.5% | 200 | -98.4% | 0.00% | -98.9% |
| Q1 2020 | $218,000 | -19.9% | 12,200 | -3.2% | 0.09% | -9.0% |
| Q4 2019 | $272,000 | +13.8% | 12,600 | -3.8% | 0.10% | +20.5% |
| Q3 2019 | $239,000 | -52.4% | 13,100 | -7.1% | 0.08% | -51.5% |
| Q2 2019 | $502,000 | +5.9% | 14,100 | 0.0% | 0.17% | +8.9% |
| Q1 2019 | $474,000 | +20.3% | 14,100 | +17.5% | 0.16% | +15.4% |
| Q4 2018 | $394,000 | -46.2% | 12,000 | 0.0% | 0.14% | -33.7% |
| Q3 2018 | $732,000 | +24.9% | 12,000 | 0.0% | 0.20% | +19.2% |
| Q2 2018 | $586,000 | -54.0% | 12,000 | 0.0% | 0.17% | -53.5% |
| Q1 2018 | $1,275,000 | +77.8% | 12,000 | 0.0% | 0.37% | +86.9% |
| Q4 2017 | $717,000 | +149.0% | 12,000 | 0.0% | 0.20% | +120.0% |
| Q3 2017 | $288,000 | – | 12,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 750,000 | $930,000 | 0.85% |
| Deep Track Capital, LP | 17,875,498 | $22,165,618 | 0.66% |
| Acuitas Investments, LLC | 879,904 | $1,091,081 | 0.58% |
| TCG Crossover Management, LLC | 4,000,000 | $4,960,000 | 0.52% |
| Almitas Capital LLC | 920,225 | $1,141,079 | 0.47% |
| Monaco Asset Management SAM | 2,166,432 | $2,686,376 | 0.43% |
| Shay Capital LLC | 1,840,377 | $2,282,067 | 0.32% |
| Nantahala Capital Management | 4,110,000 | $5,096,400 | 0.30% |
| Ikarian Capital, LLC | 1,312,405 | $1,627,382 | 0.28% |
| SAMLYN CAPITAL, LLC | 9,457,887 | $11,727,781 | 0.20% |